Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14226 - 14250 of 14684 in total
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental
Experimental
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Displaying drugs 14226 - 14250 of 14684 in total